Filing Details
- Accession Number:
- 0001415889-23-006756
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-20 16:30:13
- Reporting Period:
- 2023-04-18
- Accepted Time:
- 2023-04-20 16:30:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-04-18 | 8,000 | $113.08 | 8,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-18 | 4,710 | $226.37 | 3,420 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-18 | 2,323 | $227.10 | 1,097 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-18 | 906 | $227.96 | 191 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-18 | 61 | $229.31 | 130 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-04-19 | 8,000 | $113.08 | 8,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-19 | 2,428 | $225.43 | 5,702 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-19 | 4,772 | $226.30 | 930 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-19 | 624 | $226.88 | 306 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-19 | 176 | $228.23 | 130 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2023-04-18 | 8,000 | $0.00 | 8,000 | $113.08 |
| Common Stock | Stock Options | Disposition | 2023-04-19 | 8,000 | $0.00 | 8,000 | $113.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 80,000 | 2013-12-31 | 2023-12-31 | No | 4 | M | Direct |
| 72,000 | 2013-12-31 | 2023-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 166 | Indirect | By Spouse |
| Common Stock | 644,183 | Indirect | By Trusts |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.
- This transaction was executed in multiple trades at prices ranging from $225.835 to $226.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $226.855 to $227.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $227.89 to $228.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $224.735 to $225.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $225.74 to $226.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $226.75 to $227.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $228.14 to $228.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
